01 9Gowling WLG (Canada) LLP
01 32411468
02 32486697
03 32685831
01 3ELTROMBOPAG OLAMINE
02 6Eltrombopag Olamine
01 3TABLET
02 6Tablet
01 32021-05-24
02 32023-05-21
03 32027-08-01
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
Brand Name : REVOLADE
Patent Number : 2486697
Filing Date : 2003-05-21
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Brand Name : REVOLADE
Patent Number : 2411468
Filing Date : 2001-05-24
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-26
Brand Name : REVOLADE
Patent Number : 2685831
Filing Date : 2007-08-01
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-26
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
Brand Name : REVOLADE
Patent Number : 2486697
Filing Date : 2003-05-21
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Brand Name : REVOLADE
Patent Number : 2411468
Filing Date : 2001-05-24
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-26
Brand Name : REVOLADE
Patent Number : 2685831
Filing Date : 2007-08-01
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-26
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-06
Brand Name : REVOLADE
Patent Number : 2685831
Filing Date : 2007-08-01
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-08-01
Date Granted : 2013-11-06
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Brand Name : REVOLADE
Patent Number : 2411468
Filing Date : 2001-05-24
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-05-24
Date Granted : 2008-04-15
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
Brand Name : REVOLADE
Patent Number : 2486697
Filing Date : 2003-05-21
Strength per Unit : 75 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-21
Date Granted : 2009-01-06
LOOKING FOR A SUPPLIER?
